Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Canisius

Showing results (101-110 of 120) with videos related to

Pageof 12
Sort By:
Cancer Research|March 21, 2020
Endonuclease FEN1 Coregulates ERα Activity and Provides a Novel Drug Interface in Tamoxifen-Resistant Breast CancerKoen D Flach, Manikandan Periyasamy, Ajit Jadhav, et al.
Iscience|August 29, 2024
Predictive gene expression profile for adjuvant taxane benefit in breast cancer in the MATADOR trialMark Opdam, Annelot G J van Rossum, Marlous Hoogstraat, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2021
Differential Survival and Therapy Benefit of Patients with Breast Cancer Are Characterized by Distinct Epithelial and Immune Cell MicroenvironmentsLennart Kester, Danielle Seinstra, Annelot G J van Rossum, et al.
Genome Medicine|May 8, 2026
The contribution of rare germline variants to the immune landscape of breast cancerFelipe Rojas-Rodríguez, Sander Canisius, Renske Keeman, et al.
Oncotarget|October 30, 2016
Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21Yosr Hamdi, Penny Soucy, Véronique Adoue, et al.
Scientific Reports|October 6, 2021
Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosisMaria Escala-Garcia, Sander Canisius, Renske Keeman, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 11, 2015
Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer riskXingyi Guo, Jirong Long, Chenjie Zeng, et al.
International Journal of Cancer|April 19, 2016
Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancerJiajun Shi, Yanfeng Zhang, Wei Zheng, et al.
American Journal of Human Genetics|June 16, 2015
Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 ExpressionHatef Darabi, Karen McCue, Jonathan Beesley, et al.
Journal of the National Cancer Institute|April 20, 2015
Identification of novel genetic markers of breast cancer survivalQi Guo, Marjanka K Schmidt, Peter Kraft, et al.
Pageof 12

Showing results (101-110 of 120) with videos related to

Sort By:
Pageof 12
Cancer Research|March 21, 2020
Endonuclease FEN1 Coregulates ERα Activity and Provides a Novel Drug Interface in Tamoxifen-Resistant Breast CancerKoen D Flach, Manikandan Periyasamy, Ajit Jadhav, et al.
Iscience|August 29, 2024
Predictive gene expression profile for adjuvant taxane benefit in breast cancer in the MATADOR trialMark Opdam, Annelot G J van Rossum, Marlous Hoogstraat, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2021
Differential Survival and Therapy Benefit of Patients with Breast Cancer Are Characterized by Distinct Epithelial and Immune Cell MicroenvironmentsLennart Kester, Danielle Seinstra, Annelot G J van Rossum, et al.
Genome Medicine|May 8, 2026
The contribution of rare germline variants to the immune landscape of breast cancerFelipe Rojas-Rodríguez, Sander Canisius, Renske Keeman, et al.
Oncotarget|October 30, 2016
Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21Yosr Hamdi, Penny Soucy, Véronique Adoue, et al.
Scientific Reports|October 6, 2021
Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosisMaria Escala-Garcia, Sander Canisius, Renske Keeman, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 11, 2015
Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer riskXingyi Guo, Jirong Long, Chenjie Zeng, et al.
International Journal of Cancer|April 19, 2016
Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancerJiajun Shi, Yanfeng Zhang, Wei Zheng, et al.
American Journal of Human Genetics|June 16, 2015
Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 ExpressionHatef Darabi, Karen McCue, Jonathan Beesley, et al.
Journal of the National Cancer Institute|April 20, 2015
Identification of novel genetic markers of breast cancer survivalQi Guo, Marjanka K Schmidt, Peter Kraft, et al.
Pageof 12